K2 HealthVentures
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- United States
- United Kingdom
- Ireland
- Switzerland
Investment stages
- Series C
- Growth
Industries
- Healthcare
- Biotech
About
K2 HealthVentures is a healthcare-focused investment firm providing customized financing solutions to innovative companies. Their mission is to partner with commercial and late-stage life sciences companies to accelerate growth and create shareholder value. They operate as a strategic partner, offering deep expertise in the healthcare sector.
K2 HealthVentures is a healthcare-focused investment firm providing customized financing solutions to innovative companies. Their mission is to partner with commercial and late-stage life sciences companies to accelerate growth and create shareholder value. They operate as a strategic partner, offering deep expertise in the healthcare sector.
Investment Thesis
K2 HealthVentures provides flexible, long-term, and minimally-dilutive financing solutions to innovative life sciences and healthcare companies. They focus on commercial-stage and late development-stage companies within the biopharmaceutical, medical device, and diagnostic sectors. K2HV positions itself as a collaborative, long-term strategic partner, leveraging deep domain and capital markets expertise to help management teams accelerate growth and innovation.
Manager's Experience
The founding partners, Parag Shah and Anup Arora, each bring over 20 years of experience in healthcare finance, with previous leadership roles at Hercules Capital's Life Sciences practice. Their backgrounds include experience at major corporations like Bristol-Myers Squibb and GE Capital. The team is further strengthened by medical and scientific expertise, such as Dr. Shaan Ghandi, a former physician at Massachusetts General Hospital and venture investor at Longwood Fund, blending deep financial, operational, and clinical knowledge.
Team
Parag Shah - Founding Managing Partner & CEO
Anup Arora - Founding Managing Partner & CIO
Bob Altevogt - Managing Director
Head of Credit
John R. H. H. Plews - Managing Director
Head of Life Sciences
Shaan C. Ghandi
M.D.
D.Phil. - Managing Director
Head of Biopharma
Gerassimos G. “Makis” Spyredakis - Managing Director
Head of Medical Devices
Nimesh Shah - Managing Director
Head of Therapeutics
Portfolio
Hims & Hers
Novavax
Pacira
Radius Health
Sarepta
Veracyte
Curis
Inari Medical
Insmed
Castle Biosciences
Axsome Therapeutics
Bridgebio
Dermira
Viela Bio